NOVO-RIDAZINE 50MG 50 MG
THIORIDAZINE HYDROCHLORIDE : 50 MG · DIN 00037486 · NOVOPHARM LIMITED
Health Canada status: CANCELLED POST MARKET
What is NOVO-RIDAZINE 50MG?
NOVO-RIDAZINE 50MG 50 MG contains THIORIDAZINE HYDROCHLORIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00037486, held by NOVOPHARM LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Aug-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00037486 |
|---|---|
| Brand name | NOVO-RIDAZINE 50MG |
| Generic / active ingredient | THIORIDAZINE HYDROCHLORIDE : 50 MG |
| Manufacturer | NOVOPHARM LIMITED |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N05AC02 THIORIDAZINE |
| AHFS class | 68:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Aug-2005 |
| Original market date | 1972-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N05AC02 THIORIDAZINE. 0 of 23 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MELLARIL | 10 MG / 5 ML | SUSPENSION | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00027375 |
| MELLARIL | 30 MG | LIQUID | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00027359 |
| MELLARIL TAB 100MG | 100 MG | TABLET | SANDOZ CANADA INC | CANCELLED POST MARKET | DIN 00027553 |
| MELLARIL TAB 10MG | 10 MG | TABLET | SANDOZ CANADA INC | CANCELLED POST MARKET | DIN 00027529 |
| MELLARIL TAB 200MG | 200 MG | TABLET | SANDOZ CANADA INC | CANCELLED POST MARKET | DIN 00027561 |
| MELLARIL TAB 25MG | 25 MG | TABLET | SANDOZ CANADA INC | CANCELLED POST MARKET | DIN 00027537 |
| MELLARIL TAB 50MG | 50 MG | TABLET | SANDOZ CANADA INC | CANCELLED POST MARKET | DIN 00027545 |
| NOVO-RIDAZINE (THIORIDAZINE ORAL SUSPENSION) - 2 MG/ML | 2 MG | SUSPENSION | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02229553 |
| NOVO-RIDAZINE 100MG | 100 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00037478 |
| NOVO-RIDAZINE 10MG | 10 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00037508 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.